166480 fundamentals

CORESTEMCHEMON, Inc. engages in the development, production, and distribution of new stem cell treatments for rare and intractable diseases based on stem cell technology. It operates through the Biopharmaceutical and Non-Clinical Contract Research Organization (CRO) business divisions. The Biopharmaceutical business division conducts new foundation technology development, non-clinical studies on safety and efficacy, and productivity enhancement technology to develop stem cell-based treatment. The Non-Clinical Contract Research Organization (CRO) business division provides a range of research and development services required in all processes of exploring and developing new substances such as pharmaceuticals, food, chemicals, and cosmetics. The company was founded on December 29, 2003 and is headquartered in Seongnam-si, South Korea.